A federal court has upheld an Oklahoma law that prohibits healthcare providers from doing cosmetic sex change surgeries and prescribing puberty blockers for trans-identified minors.
The U.S. District Court for the Northern District of Oklahoma issued an opinion and order last Thursday that upheld Oklahoma’s Senate Bill 613, which was signed into law in May.
“Plaintiffs have not demonstrated a fundamental right for parents to choose for their children to use puberty blockers, cross-sex hormones, and surgeries for the purpose of effectuating a gender transition,” read the decision.
“It is rational for the Oklahoma Legislature to regulate the Treatment Protocols for minors while the democratic process resolves ongoing questions of safety and efficacy. … Indeed, courts have upheld restrictions designed to protect and prevent minors from engaging in behaviors that are far less risky than the procedures banned by SB 613.”